US · Healthcare · Medical Devices
EPS came in at 2.92 against a street estimate of 2.51 — a beat of 16.3%.
Analysts rate UFP Technologies Inc a buy (2 buy, 2 hold, 0 sell out of 4) with an average price target of $355.00.
CONFIDENT Q2 beat expectations with 15.1% revenue growth and record $2.92 adjusted EPS. Broad-based growth across MedTech portfolio, Dominican Republic investments gaining traction. Management confident in acquisition pipeline and long-term strategy. Q2 2026 Dominican Republic expansion ongoing; 2 of 3 planned program transfers completed, third delayed pending customer qualification. St. Charles labor issues fully resolved. Analysts pressed on AJR recovery trajectory, new program contribution timing, and future growth rates. Management emphasized broad-based growth not concentrated in launches, clarified Q2 comp was low point for labor, and declined rest-of-year guidance citing improving prior-year comparisons. 2026-08-04…
Full summary in the app.
| Fund | Stake |
|---|---|
| BlackRock Inc | 14.16% |
| Congress Asset Management Company, LLP | 8.88% |
| Wasatch Advisors LP | 8.82% |
| BTIM Corp | 4.34% |
| Vanguard Capital Management, LLC | 4.22% |
| State Street Corp | 3.92% |
| Neuberger Berman Group LLC | 3.88% |
| American Century Companies Inc | 3.61% |
| Document | Date |
|---|---|
| Reg FD disclosure · Q3 2026 UFP TECHNOLOGIES, INC. - FORM 8-K SUMMARY DOCUMENT PURPOSE & NATURE • This is a Form 8-K Current Report filed August 24, 2026 by UFP Technologies, I | 2026-08-24 |
| Quarterly report · Q2 2026 UFP TECHNOLOGIES, INC. – Q2 2026 SUMMARY HEADLINE NUMBERS • Net sales Q2 2026: $173,964 thousand vs. $151,176 thousand Q2 2025 (+15.1%) • Net sales | 2026-08-06 |
| Results announced · Q3 2026 UFP TECHNOLOGIES Q2 2026 EARNINGS SUMMARY HEADLINE NUMBERS • Q2 2026 Net Sales: $174.0 million, up 15.1% vs Q2 2025 ($151.2 million) • Q2 2026 Net I | 2026-08-03 |
| Board / officer change · Q2 2026 UFP TECHNOLOGIES, INC. - FORM 8-K SUMMARY Report Date: June 4, 2026 --- BUSINESS & SEGMENT HIGHLIGHTS • New Chief Executive Officer Appointed: Mitc | 2026-06-10 |
| Reg FD disclosure · Q2 2026 UFP TECHNOLOGIES, INC. - FORM 8-K SUMMARY HEADLINE NUMBERS • No financial results or specific numbers disclosed in this filing • This is a disclosure | 2026-06-08 |
| Quarterly report · Q1 2026 UFP TECHNOLOGIES, INC. - Q1 2026 SUMMARY HEADLINE NUMBERS • Net Sales: $154.2 million (Q1 2026) vs. $148.1 million (Q1 2025) — up 4.1% • Net Income: | 2026-05-08 |
| Proxy statement · Q2 2026 UFP TECHNOLOGIES, INC. – PROXY STATEMENT SUMMARY Annual Meeting: June 4, 2026 --- WHAT SHAREHOLDERS ARE VOTING ON • Proposal 1: Elect seven directo | 2026-04-30 |
| Annual report FY2025 UFP TECHNOLOGIES, INC. – 2025 10-K SUMMARY HEADLINE NUMBERS • Market capitalization: approximately $1.81 billion as of June 30, 2025 (based on $244. | 2026-02-27 |
Readable in the app.
| Announcement | Date |
|---|---|
| Extended supply agreement with strategic customer through 2029, increased volumes UFP Technologies signed Amendment No. 27 to its manufacturing supply agreement with Intuitive Surgical, a major customer, on February 19, 2026. The amendment extends the contract by two year | 2026-02-24 |
Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for UFP Technologies Inc — free to start.
Google PlayApp StoreData updated 2026-09-18.